Amorphastilbol exerts beneficial effects on glucose and lipid metabolism in mice consuming a high-fat-diet
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Woojung | - |
dc.contributor.author | Ham, Jungyeob | - |
dc.contributor.author | Kwon, Hak Cheol | - |
dc.contributor.author | Yoon, Goo | - |
dc.contributor.author | Bae, Gyu-Un | - |
dc.contributor.author | Kim, Yong Kee | - |
dc.contributor.author | Kim, Su-Nam | - |
dc.date.available | 2021-02-22T11:34:45Z | - |
dc.date.issued | 2015-08 | - |
dc.identifier.issn | 1107-3756 | - |
dc.identifier.issn | 1791-244X | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/10462 | - |
dc.description.abstract | In the present study, the anti-diabetic effects of amorphastilbol (APH) from Amorpha fruticosa (AF) were evaluated in high-fat-diet (HFD) mice. HFD-induced blood glucose and insulin levels are significantly reduced in AF extract or APH treatment groups. HFD-induced weight gain was reduced by AF treatment, which is accompanied by reduction of fat mass and adipocyte size and number in white adipose tissues. Furthermore, total cholesterol and low-density lipoprotein-cholesterol levels are decreased in AF- or APH-treated mice. In addition, AF and APH are able to improve insulin sensitivity through inhibition of protein tyrosine phosphatase 1B, a negative regulator of the insulin-signaling pathway. Taken together, the data suggest that AF has beneficial effects on glucose and lipid metabolism and its pharmacological effects are driven, in part, by its active component, APH. Therefore, AF and APH can be used as potential therapeutic agents against type 2 diabetes and associated metabolic disorders, including obesity, by enhancing glucose and lipid metabolism. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.title | Amorphastilbol exerts beneficial effects on glucose and lipid metabolism in mice consuming a high-fat-diet | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/ijmm.2015.2227 | - |
dc.identifier.scopusid | 2-s2.0-84934268197 | - |
dc.identifier.wosid | 000358677000024 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, v.36, no.2, pp 527 - 533 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | - |
dc.citation.volume | 36 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 527 | - |
dc.citation.endPage | 533 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | PROTEIN-TYROSINE PHOSPHATASES | - |
dc.subject.keywordPlus | PPAR-ALPHA/GAMMA AGONIST | - |
dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | WEIGHT | - |
dc.subject.keywordPlus | ROSIGLITAZONE | - |
dc.subject.keywordPlus | MURAGLITAZAR | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordAuthor | Amorpha fruticosa | - |
dc.subject.keywordAuthor | amorphastilbol | - |
dc.subject.keywordAuthor | peroxisome proliferator-activated receptor alpha/gamma agonist | - |
dc.subject.keywordAuthor | protein tyrosine phosphatase 1B | - |
dc.subject.keywordAuthor | insulin resistance | - |
dc.identifier.url | https://www.spandidos-publications.com/10.3892/ijmm.2015.2227 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.